{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:48:05Z","timestamp":1762004885547,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-AI103497","K24-AI080942"],"award-info":[{"award-number":["R21-AI103497","K24-AI080942"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","award":["Commonwealth University Health Enhancement (CURE) grant"],"award-info":[{"award-number":["Commonwealth University Health Enhancement (CURE) grant"]}],"id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U54-CK000163"],"award-info":[{"award-number":["U54-CK000163"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12941-017-0202-4","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T04:07:12Z","timestamp":1491624432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli"],"prefix":"10.1186","volume":"16","author":[{"name":"on behalf of the CDC prevention epicenters program","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-6732","authenticated-orcid":false,"given":"Pinyo","family":"Rattanaumpawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving","family":"Nachamkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren B.","family":"Bilker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Metlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebbing","family":"Lautenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"key":"202_CR1","volume-title":"Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20. Wayne: CLSI; 2010."},{"key":"202_CR2","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1128\/AAC.45.11.3084-3091.2001","volume":"45","author":"LC McDonald","year":"2001","unstructured":"McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, Huang CH, et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother. 2001;45:3084\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"202_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/653931","volume":"51","author":"E Lautenbach","year":"2010","unstructured":"Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, et al. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis. 2010;51:280\u20135.","journal-title":"Clin Infect Dis"},{"key":"202_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0732-8893(99)00121-2","volume":"36","author":"AC Gales","year":"2000","unstructured":"Gales AC, Gordon KA, Wilke WW, Pfaller MA, Jones RN. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America. Diagn Microbiol Infect Dis. 2000;36:61\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"202_CR5","doi-asserted-by":"publisher","first-page":"4p","DOI":"10.1186\/1471-2334-4-36","volume":"4","author":"R Slinger","year":"2004","unstructured":"Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis. 2004;4:4p.","journal-title":"BMC Infect Dis"},{"key":"202_CR6","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1371\/journal.pntd.0001163","volume":"5","author":"CM Parry","year":"2011","unstructured":"Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, et al. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis. 2011;5:e1163.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"202_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jac\/dkv400","volume":"71","author":"CN Thompson","year":"2016","unstructured":"Thompson CN, Thieu NT, Vinh PV, Duc AN, Wolbers M, Vinh H, et al. Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections. Antimicrob Chemother. 2016;71(3):807\u201315.","journal-title":"Antimicrob Chemother"},{"issue":"5","key":"202_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/jac\/dku548","volume":"70","author":"P Rattanaumpawan","year":"2015","unstructured":"Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, et al. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case\u2013control study. J Antimicrob Chemother. 2015;70(5):1547\u201351.","journal-title":"J Antimicrob Chemother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-017-0202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-017-0202-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-017-0202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:04:15Z","timestamp":1589475855000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-017-0202-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/s12941-017-0202-4","relation":{},"ISSN":["1476-0711"],"issn-type":[{"type":"electronic","value":"1476-0711"}],"subject":[],"published":{"date-parts":[[2017,4,8]]},"assertion":[{"value":"14 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}